Sponsored by:

Complimentary Virtual Conference

October 15, 2019 | 1:00 p.m. - 4:05 pm ET

Wearables: The Small Parts Drive Innovation

With consumers demanding more control over managing their health, the wearables market is rapidly expanding. Various estimates of market growth range from 15% to nearly 25% over the next five years. Medtech companies, along with other technology companies looking to enter this space, will continue to innovate to meet user needs. Join MedTech Intelligence for this special web seminar as we explore wearable medical technology and its potential in transforming the industry. A Q&A with the speakers will follow each session.

Learning Objectives:

Attendees will learn about:

  • Current trends in wearable technology
  • How components are enabling innovation
  • New/emerging features in components for wearables

Who Should Attend:

  • Product design and engineering
  • Business development
  • IT


1:00 pm – 1:05 pm  Welcome and Introduction
Maria Fontanazza – Editor-in-Chief, MedTech Intelligence

1:05 pm – 1:40 pm Trends in wearable technology- Landscape and potential
Greg Caressi, Senior Vice President and Global Business Unit Leader for Transformational Health, Frost & Sullivan

1:40 pm – 1:55 pm Technology Spotlight: AccuMold 

1:55 pm – 2:05 pm Q & A Session

2:05 pm - 2:40 pm Emerging technology in components: The small parts that drive big innovation (i.e., use of sensors & electronics, materials & fabrics)
Mike Klawitter, Business Development Manager, Innovize
Oxana Pantchenko, Ph.D., Human Monitoring Lead & Engineering Project Manager, NextFlex

2:40 pm – 2:55 pm Technology Spotlight: 3M
Del R. Lawson, Ph.D., R&D Manager, 3M's Medical Solutions Division

2:55 pm –3:05 pm & A Session

3:05 pm – 3:40 pm Bringing it all together: The integration of smart (plus generating actionable data)
Christopher McCann, CEO & Co-Founder, Current Health

3:40 pm - 4:00 pQ & A Session

4:00 pm – Adjournment


Greg Caressi
Global Business Unit Leader - Transformational Health
Frost & Sullivan

Greg Caressi is the global business unit leader for the Transformational Health practice at Frost & Sullivan, leading research, consulting and sales teams across the Digital Health, Pharma 2.0, Next Generation Diagnostics, Medical Devices and Medical Imaging & Informatics programs. In addition to his leadership responsibilities, Caressi spends much of his time working on strategic consulting projects on next-generation healthcare solutions, drawing insights from interactions with healthcare providers, payors, medtech vendors and other healthcare stakeholders. He served for two years as the chair of the HIMSS Life Sciences Information Technology Committee, where he led the creation of industry guidance for Good Informatics Practices used by life science companies, from startups to major pharmaceutical companies. Caressi regularly serves as chair, speaker and leader of interactive workshops at major industry events in the United States, Asia, and Latin America. Recent workshops have focused on digital transformation of medtech companies, developing a next-generation patient engagement platform and marketing and competitive intelligence strategy planning for new product launches.

Mike Klawitter
Business Development Manager,


Mike Klawitter joined Innovize in 2018 with more than 30 years of experience in converting and manufacturing. During his career he has provided leadership to product development, customer service, sales and marketing teams. Prior to joining Innovize, Klawitter held the position of Vice President of Sales, Healthcare Solutions for a global converting organization. 

Del R. Lawson, Ph.D.
New Product Development Lead
Medical Solutions Division

Del R. Lawson, Ph.D received his BS in chemistry from California State University at Fresno, and his Ph.D. in chemistry from Texas A&M University. Lawson has more than 25 years of experience at 3M in laboratory management, strategic product platform creation, and Lean Six Sigma operations. His experience has involved new technology creation in advanced analytics and sensors, biotechnology solutions, and medical adhesives. Lawson currently leads new product development and commercialization efforts in 3M’s Medical Solutions Division.

Oxana Pantchenko, Ph.D.
Lead - Human Monitoring & Project Manager

Oxana Pantchenko, Ph.D. earned her Ph.D. degree in electrical engineering from the University of California, Santa Cruz. Currently, she is a Lead of Human Monitoring and a Project Manager at NextFlex, located in San Jose, CA. Her past experience includes work at the U.S. Food and Drug Administration: Center for Devices and Radiological Health, San Jose State University, Foothill Community College, and Profusa, Inc.

Christopher McCann
CEO and Co-Founder
Current Health

Maria Fontanazza
MedTech Intelligence


Maria Fontanazza has more than 15 years of experience in journalism, marketing, and communications. She was previously marketing communications manager and market research manager at Secant Medical, Inc., a manufacturer of biomedical textiles and advanced biomaterials. Maria also served as an editor at MD+DI and has authored articles that have appeared in domestic and international industry publications. She has a B.A. in Journalism and Mass Communications with a concentration in New Media and Visual Design, and a Minor in Fine Arts, from St. Michael’s College in Colchester, VT.

Share This